(Q38020247)

27 August 2017

Current progress in using vitamin D and its analogs for cancer prevention and treatment (English)

1 reference

27 August 2017

0 references

Florence S G Cheung

1

1 reference

PubMed ID

22716497

27 August 2017

Frank J Lovicu

series ordinal

2

1 reference

PubMed ID

22716497

27 August 2017

Juergen K V Reichardt

series ordinal

3

1 reference

27 August 2017

1 June 2012

1 reference

Expert Review of Anticancer Therapy

27 August 2017

1 reference

27 August 2017

12

1 reference

27 August 2017

6

1 reference

27 August 2017

811-837

1 reference

Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3).

27 August 2017

1 reference

Do sunlight and vitamin D reduce the likelihood of colon cancer?

21 January 2018

1 reference

A critical review of studies on vitamin D in relation to colorectal cancer

21 January 2018

1 reference

An ecological study of cancer incidence and mortality rates in France with respect to latitude, an index for vitamin D production

21 January 2018

1 reference

Prostate cancer incidence in Australia correlates inversely with solar radiation

21 January 2018

1 reference

Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis.

21 January 2018

1 reference

Residential sunlight exposure is associated with a decreased risk of prostate cancer

21 January 2018

1 reference

Ultraviolet sunlight exposure during adolescence and adulthood and breast cancer risk: a population-based case-control study among Ontario women

21 January 2018

1 reference

An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking.

21 January 2018

1 reference

Geographical distribution for malignant neoplasm of the pancreas in relation to selected climatic factors in Japan

21 January 2018

1 reference

The effect of solar UVB doses and vitamin D production, skin cancer action spectra, and smoking in explaining links between skin cancers and solid tumours

21 January 2018

1 reference

Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis.

21 January 2018

1 reference

Intake of dairy products, calcium, and vitamin d and risk of breast cancer

21 January 2018

1 reference

Meta-analysis of vitamin D, calcium and the prevention of breast cancer

21 January 2018

1 reference

Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness

21 January 2018

1 reference

Seasonal variations in vitamin D status and calcium absorption do not influence bone turnover in young women.

21 January 2018

1 reference

Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies

21 January 2018

1 reference

Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk

21 January 2018

1 reference

Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma

21 January 2018

1 reference

Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study

21 January 2018

1 reference

Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study

21 January 2018

1 reference

Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study

21 January 2018

1 reference

Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer

21 January 2018

1 reference

Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study

21 January 2018

1 reference

Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers

21 January 2018

1 reference

Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II

21 January 2018

1 reference

Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial

21 January 2018

1 reference

Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men.

21 January 2018

1 reference

Serum vitamin D concentration and prostate cancer risk: a nested case-control study

21 January 2018

1 reference

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries

21 January 2018

1 reference

Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?

21 January 2018

1 reference

Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006)

21 January 2018

1 reference

Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study

21 January 2018

1 reference

Vitamin D intake and the risk for pancreatic cancer in two cohort studies

21 January 2018

1 reference

Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

21 January 2018

1 reference

Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial

21 January 2018

1 reference

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

21 January 2018

1 reference

Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

21 January 2018

1 reference

NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary

21 January 2018

1 reference

Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology

21 January 2018

1 reference

HGBASE: a database of SNPs and other variations in and around human genes

21 January 2018

1 reference

Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

21 January 2018

1 reference

Growth regulation of human colon cancer cells by epidermal growth factor and 1,25-dihydroxyvitamin D3 is mediated by mutual modulation of receptor expression

21 January 2018

1 reference

Signaling pathways in intestinal development and cancer

21 January 2018

1 reference

Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.

21 January 2018

1 reference

The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression

21 January 2018

1 reference

Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3.

21 January 2018

1 reference

RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells

21 January 2018

1 reference

The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling

21 January 2018

1 reference

Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment

21 January 2018

1 reference

Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.

21 January 2018

1 reference

Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b

21 January 2018

1 reference

DNA methylation-related vitamin D receptor insensitivity in breast cancer

21 January 2018

1 reference

Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues

21 January 2018

1 reference

The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression

21 January 2018

1 reference

Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells

21 January 2018

1 reference

Calcium signaling in cancer and vitamin D.

21 January 2018

1 reference

Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression

21 January 2018

1 reference

Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer

21 January 2018

1 reference

Constitutive activation of the mitogen-activated protein kinase pathway impairs vitamin D signaling in human prostate epithelial cells

21 January 2018

1 reference

1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells.

21 January 2018

1 reference

Vitamin D and differentiation in cancer

21 January 2018

1 reference

Androgen receptor signaling and vitamin D receptor action in prostate cancer cells

21 January 2018

1 reference

Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer

21 January 2018

1 reference

The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).

21 January 2018

1 reference

Role of supplemental calcium in the recurrence of colorectal adenomas: a metaanalysis of randomized controlled trials

21 January 2018

1 reference

Vitamin D, Cod-Liver Oil, Sunlight, and Rickets: A Historical Perspective

21 January 2018

1 reference

Mechanism and potential of the growth-inhibitory actions of vitamin D and ana-logs.

21 January 2018

1 reference

Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells

21 January 2018

1 reference

19-nor-1 alpha,25-dihydroxyvitamin D2 (paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo

21 January 2018

1 reference

MNU-induced mammary gland carcinogenesis: chemopreventive and therapeutic effects of vitamin D and Seocalcitol on selected regulatory vitamin D receptor pathways

21 January 2018

1 reference

EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells

21 January 2018

1 reference

Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group

21 January 2018

1 reference

The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells

21 January 2018

1 reference

Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia.

21 January 2018

1 reference

The prevention of prostate cancer--the dilemma continues

21 January 2018

1 reference

CD-ring modified vitamin D3 analogs and their superagonistic action.

21 January 2018

1 reference

Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel

21 January 2018

1 reference

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer

21 January 2018

1 reference

Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer

21 January 2018

1 reference

High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II study

21 January 2018

1 reference

Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy

21 January 2018

1 reference

Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of calcitriol, in patients with cancer

21 January 2018

1 reference

A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer

21 January 2018

1 reference

A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors.

21 January 2018

1 reference

A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors

21 January 2018

1 reference

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

21 January 2018

1 reference

A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer

21 January 2018

1 reference

Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer

21 January 2018

1 reference

BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial

21 January 2018

1 reference

Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer

21 January 2018

1 reference

A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations

21 January 2018

1 reference

A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk

21 January 2018

1 reference

Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk

21 January 2018

1 reference

A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer

21 January 2018

1 reference

Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis

21 January 2018

1 reference

Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer

21 January 2018

1 reference

Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population

21 January 2018

1 reference

Vitamin D receptor gene polymorphisms and breast cancer risk

21 January 2018

1 reference

Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review

21 January 2018

1 reference

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer

21 January 2018

1 reference

Sequence variants in the human 25-hydroxyvitamin D3 1-alpha-hydroxylase (CYP27B1) gene are not associated with prostate cancer risk

21 January 2018

1 reference

Vitamin D pathway gene variants and prostate cancer risk

21 January 2018

1 reference

21 January 2018

1 reference

Vitamin D pathway gene variants and prostate cancer prognosis

21 January 2018

1 reference

21 January 2018

1 reference

Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study

21 January 2018

1 reference

Circulating 25-Hydroxyvitamin D Levels Predict Survival in Early-Stage Non–Small-Cell Lung Cancer Patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERA.12.53

1 reference

27 August 2017

1 reference

PubMed ID

22716497